SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-033372
Filing Date
2023-09-21
Accepted
2023-09-21 17:29:15
Documents
13
Period of Report
2023-09-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49553
2 ex3-1.htm EX-3.1 178066
  Complete submission text file 0001493152-23-033372.txt   444960

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcsa-20230918.xsd EX-101.SCH 3060
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcsa-20230918_lab.xml EX-101.LAB 34240
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcsa-20230918_pre.xml EX-101.PRE 22389
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3420
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 231269853
SIC: 2834 Pharmaceutical Preparations